Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,047 signal articles · 242 in last 24h · 119,456 total before filter · latest 1h ago
242last 24h
1501last 7d
250● bullish (7d)
157● bearish (7d)
205publishers
AllMacro289Earnings580M&A107Regulatory20Product13Analyst21
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Investing.com14d agobullish
AZN spikes 6% after report it denies AstraZeneca-BMS merger talks

AstraZeneca (NASDAQ: AZN) and Bristol Myers Squibb (NYSE: BMY) are the two directly affected public companies; AZN bears the most immediate price risk given it absorbed a roughly 9% single-day selloff on Monday when the merger speculation first emerged, while BMY shareholders were widely viewed as the primary beneficiaries of any combination.

This Week In Electric Vehicles - Battery Market's Billion-Dollar Surge Powers Global Growth
Simply Wall St.14d agobullish
This Week In Electric Vehicles - Battery Market's Billion-Dollar Surge Powers Global Growth

The global electric vehicle (EV) battery market is poised for significant growth, with projections indicating an increase from USD 103.04 billion in 2026 to USD 168.95 billion by 2035, driven by a compound annual growth rate of 5.6%. This expansion is fueled by the rising adoption of battery electric vehicles (BEVs), decreased battery pack prices, investments in local manufacturing, and advancements in fast-charging technologies and battery architectures. The 50-110 kWh battery capacity...

Investing.com14d agobullish
Shopify surges, AMD slides premarket as earnings disappoint

Investing.com - U.S. stock index futures were broadly higher on Wednesday as investors drew cautious optimism from signs that negotiations to reopen the Strait of Hormuz could be gaining traction, although disappointing reactions to earnings from Advanced Micro Devices and privately held SpaceX tempered enthusiasm for technology shares.

Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout
Insider Monkey14d agobullish
Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout

Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 Health Care Index and the 15.44% gain for the Russell 3000 Index. Since inception, […]

Regal Rexnord (RRX) Tops Q2 Earnings Estimates
Zacks14d agobullish
Regal Rexnord (RRX) Tops Q2 Earnings Estimates

Regal Rexnord (RRX) delivered earnings and revenue surprises of +15.00% and -1.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?